Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Herer Group is a vertically integrated cannabis organization that focuses on the intersection of genetics, laboratory science, and consumer products. Founded by Dan Herer to honor the legacy of his father, Jack Herer, the company operates through specialized divisions such as Herer Genetics and Herer Labs to stabilize and standardize cannabis cultivars. Their primary business involves the development of high-quality cannabis strains and products designed for both therapeutic and adult-use markets. By utilizing advanced genomic mapping and chemical analysis, Herer Group aims to provide consistent cannabinoid and terpene profiles for medical applications. The company is headquartered in California and serves as a prominent player in the state's regulated cannabis and life sciences ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Herer Group.